Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CTNM stock hub

Contineum Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CTNMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

542.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CTNM

In the news

Latest news · CTNM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-26.9

P25 -106.6P50 -46.9P75 -3.1

ROIC-786

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CTNM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001855175
Company name	Contineum Therapeutics, Inc.
Country	United States
Country code	US
Cusip	21217B100
Employees	51
Employees Change	10%
Employees Change Percent	24.39
Enterprise value	$303.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-04-05
Isin	US21217B1008
Last refreshed	2026-05-10
Market cap	$542.5M
Market cap category	Small-Cap
Price	$14.53
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CTNM
Website	https://www.contineum-tx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.77%
P/B ratio	2.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-58.4M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.1M
ROA	-18.18
ROCE	-26.25
ROE	-26.88
ROIC	-786

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	264.48%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$261.3M
Cash	$246.3M
Current Assets	$253M
Current Liabilities	$6.7M
Debt	$7M
Debt Equity	$0.03
Equity	$250M
Liabilities	$11.3M
Long Term Assets	$8.4M
Long Term Liabilities	$4.7M
Net Cash	$239.4M
Net Cash By Market Cap	$44.12
Net Cash Growth	29.6%
Net Debt Equity	$-0.96
Tangible Book Value	$250M
Tangible Book Value Per Share	$6.69
WACC	9.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	38
Net Working Capital	$2.3M
Quick ratio	37
Working Capital	$246.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	264.16%
200-day SMA	11.78
50-day SMA	13.36
50-day SMA vs 200-day SMA	50over200
All Time High	22
All Time High Change	-33.95%
All Time High Date	2024-07-01
All Time Low	3.35
All Time Low Change	333.73%
All Time Low Date	2025-05-28
ATR	0.9
Beta	0.89
Beta1y	-0.13
Beta2y	0.57
Ch YTD	27.12
High	14.89
High52	16.33
High52 Date	2026-02-24
High52ch	-11.02%
Low	14.31
Low52	3.35
Low52 Date	2025-05-29
Low52ch	333.73%
Ma50ch	8.8%
Price vs 200-day SMA	23.4%
RSI	60.85
RSI Monthly	54.04
RSI Weekly	58.7
Sharpe ratio	1.78x
Sortino ratio	3.33
Total Return	-21.17%
Tr YTD	27.12
Tr1m	14.14%
Tr1w	10.08%
Tr3m	-3.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$18
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.54
Operating Income	$-66.9M
Price target	$19
Price Target Change	$30.76
Price Target Change Top	$23.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,364,615%
Float Percent	67.94%
Shares Insiders	0.83%
Shares Institutions	61.03%
Shares Out	37,336,036
Shares Qo Q	20.98%
Shares Yo Y	21.17%
Short Float	12.22%
Short Ratio	8.4
Short Shares	8.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	289,805.25x
Bv Per Share	6.69
Ch1m	14.14
Ch1w	10.08
Ch1y	264.2
Ch3m	-3.13
Ch6m	33
Change	-0.68%
Change From Open	-0.55
Close	14.63
Days Gap	-0.14
Depreciation Amortization	325,750
Dollar Volume	1,937,866.1
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-66.9M
EBITDA	$-66.5M
EPS	$-1.91
F Score	1
Fiscal Year End	December
Founded	2,009
Ipr	-9.19
Iprfo	0.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	12.56
Ma150ch	15.65%
Ma20	13.32
Ma20ch	9.07%
Next Earnings Date	2026-08-04
Open	14.61
Optionable	Yes
Position In Range	37.93
Ppne	8,073,000
Price Date	2026-05-08
Ptbv Ratio	2.17
Relative Volume	0.46x
Tr6m	33%
Us State	California
Volume	133,370

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CTNM pay a dividend?

Capital-return profile for this ticker.

Performance

CTNM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CTNM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+61.0%

Float: +67.9% of shares outstanding

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CTNM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.9

Neutral momentum band

Price vs 200-day MA

+23.4%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

1.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CTNM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CTNM stock rating?

Contineum Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CTNM analysis?

The full report lives at /stocks/CTNM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CTNM?

The latest report frames CTNM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CTNM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.